[
    [
        {
            "time": "2018-08-21",
            "original_text": "中银国际*每日速递20180821：飞凯材料、汇川技术、天士力、沃森生物、通威股份、舍得酒业、岭南股份、烽火通信、中国巨石等",
            "features": {
                "keywords": [
                    "飞凯材料",
                    "汇川技术",
                    "天士力",
                    "沃森生物",
                    "通威股份",
                    "舍得酒业",
                    "岭南股份",
                    "烽火通信",
                    "中国巨石"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "科技",
                    "新能源",
                    "消费品",
                    "通信",
                    "建材"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中银国际*每日速递20180821：飞凯材料、汇川技术、天士力、沃森生物、通威股份、舍得酒业、岭南股份、烽火通信、中国巨石等",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-08-21",
            "original_text": "【医药】沃森生物：2018H1扭亏为盈，静待PCV13获批",
            "features": {
                "keywords": [
                    "沃森生物",
                    "扭亏为盈",
                    "PCV13",
                    "获批"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】沃森生物：2018H1扭亏为盈，静待PCV13获批",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]